Thank you for supporting our clinical path to meaningful therapeutic innovation.
We are grateful that you see the value in our work and are willing to support it despite the lack of tax advantages and high risk. Your decision to participate in the funding of an innovation long before it is “de‑risked” enough for venture capital is both rare and courageous. So, your support matters deeply. Thank you.
